Haig Bozigian

Pharmacologic Characterization of Valbenazine (NBI-98854) and Its Metabolites

Dimitri E. Grigoriadis, Evan Smith, Sam R.J. Hoare et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 252 citations · Full text

Suppression of Gonadotropins and Estradiol in Premenopausal Women by Oral Administration of the Nonpeptide Gonadotropin-Releasing Hormone Antagonist Elagolix

R. Scott Struthers, Andrew Nicholls, John S. Grundy et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 121 citations · Full text

Design of 2,5-Dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylaminopyrazolo[1,5-<i>a</i>]pyrimidine (NBI 30775/R121919) and Structure−Activity Relationships of a Series of Potent and Orally Active Corticotropin-Releasing Factor Receptor Antagonists

Chen Chen, Keith Wilcoxen, Charles Q. Huang et al. · Journal of Medicinal Chemistry · 2004 · 117 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Crf-stimulated Acth Release +13

Discovery of Sodium <i>R</i>-(+)-4-{2-[5-(2-Fluoro-3-methoxyphenyl)-3-(2-fluoro-6-[trifluoromethyl]benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2<i>H</i>-pyrimidin-1-yl]-1-phenylethylamino}butyrate (Elagolix), a Potent and Orally Available Nonpeptide Antagonist of the Human Gonadotropin-Releasing Hormone Receptor

Chen Chen, Dongpei Wu, Zhiqiang Guo et al. · Journal of Medicinal Chemistry · 2008 · 117 citations · Full text

Novel Uracil Phenylethylamines, Gynecology, Pharmacotherapy +16

Distribution, excretion, and metabolism of butylbenzyl phthalate in the rat

David A. Eigenberg, Haig Bozigian, Dean E. Carter et al. · Journal of Toxicology and Environmental Health · 1986 · 72 citations

Iv Administration, Endocrine Disruptors, Biochemistry +15